Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Robey

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|March 29, 2008
ABCG2: structure, function and role in drug responseOrsolya Polgar, Robert W Robey, Susan E Bates
Molecular Pharmacology|March 4, 2008
P-glycoprotein--a clinical target in drug-refractory epilepsy?Robert W Robey, Alberto Lazarowski, Susan E Bates
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
CCR 20th Anniversary Commentary: Expanding the Epigenetic Therapeutic PortfolioSusan E Bates, Robert W Robey, Richard L Piekarz
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
New mechanisms of multidrug resistance: an introduction to the <i>Cancer Drug Resistance</i> special collectionMichael M Gottesman, Robert W Robey, Suresh V Ambudkar
Cancer Biology & Therapy|February 3, 2005
ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapyRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
Current Pharmaceutical Biotechnology|December 2, 2010
The challenge of exploiting ABCG2 in the clinicRobert W Robey, Caterina Ierano, Zhirong Zhan, et al.
F1000Research|February 15, 2020
Multidrug transporters: recent insights from cryo-electron microscopy-derived atomic structures and animal modelsSabrina Lusvarghi, Robert W Robey, Michael M Gottesman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 31, 2008
Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2Suneet Shukla, Robert W Robey, Susan E Bates, et al.
Biochemistry|July 19, 2006
The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2Suneet Shukla, Robert W Robey, Susan E Bates, et al.
The Journal of Biological Chemistry|September 8, 2006
Characterization of gene rearrangements leading to activation of MDR-1Lyn M Huff, Jong-Seok Lee, Robert W Robey, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Expert Opinion on Drug Metabolism & Toxicology|March 29, 2008
ABCG2: structure, function and role in drug responseOrsolya Polgar, Robert W Robey, Susan E Bates
Molecular Pharmacology|March 4, 2008
P-glycoprotein--a clinical target in drug-refractory epilepsy?Robert W Robey, Alberto Lazarowski, Susan E Bates
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
CCR 20th Anniversary Commentary: Expanding the Epigenetic Therapeutic PortfolioSusan E Bates, Robert W Robey, Richard L Piekarz
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
New mechanisms of multidrug resistance: an introduction to the <i>Cancer Drug Resistance</i> special collectionMichael M Gottesman, Robert W Robey, Suresh V Ambudkar
Cancer Biology & Therapy|February 3, 2005
ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapyRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
Current Pharmaceutical Biotechnology|December 2, 2010
The challenge of exploiting ABCG2 in the clinicRobert W Robey, Caterina Ierano, Zhirong Zhan, et al.
F1000Research|February 15, 2020
Multidrug transporters: recent insights from cryo-electron microscopy-derived atomic structures and animal modelsSabrina Lusvarghi, Robert W Robey, Michael M Gottesman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 31, 2008
Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2Suneet Shukla, Robert W Robey, Susan E Bates, et al.
Biochemistry|July 19, 2006
The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2Suneet Shukla, Robert W Robey, Susan E Bates, et al.
The Journal of Biological Chemistry|September 8, 2006
Characterization of gene rearrangements leading to activation of MDR-1Lyn M Huff, Jong-Seok Lee, Robert W Robey, et al.
Pageof 13